Research programme: gram-negative infection therapeutics - Oppilotech
Alternative Names: Potentiator agents - OppilotechLatest Information Update: 28 May 2021
At a glance
- Originator Oppilotech
- Class
- Mechanism of Action Bacterial outer membrane protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gram-negative infections
Most Recent Events
- 28 May 2021 No recent reports of development identified for research development in Gram-negative-infections in United Kingdom
- 06 Apr 2017 Early research in Gram-negative infections in United Kingdom (unspecified route)